Vitamin D status and mortality in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3603-3609

  Pilz, Stefan ^a,b   Tomaschitz, Andreas ^a   Friedl, Claudia ^a   Amrein, Karin ^a   Drechsler, Christiane ^c   Ritz, Eberhard ^d   Boehm, Bernhard O ^e   Grammer, Tanja B ^a,d,f   März, Winfried ^a,d,f  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f SYNLAB ACADEMY   (Germany)

Author keywords

death; mortality; prospective; renal; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80052151436     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr076     Document Type: Article

References (44)

1. Mehrotra R, Kermah D, Budoff M et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1144-1151
2. Jacob AI, Sallman A, Santiz Z et al. Defective photoproduction of cholecalciferol in normal and uremic humans. J Nutr 1984; 114: 1313-1319
3. Doorenbos CR, von den Born J, Navis G et al. Possible renoprotection by vitamin D in renal disease: Beyond mineral metabolism. Nat Rev Nephrol 2009; 5: 691-700
4. Zhang Y, Kong J, Deb DK et al. Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol 2010; 21: 966-973
5. Melamed ML, Astor B, Michos ED et al. 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 2009; 20: 2631-2639
6. Rojas-Rivera J, De La Piedra C, Ramos A et al. The expanding spectrum of biological actions of vitamin D. Nephrol Dial Transplant 2010; 25: 2850-2865
7. García-Canton C, Bosch E, Ramírez A et al. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant. doi: 10.1093/ ndt/gfq650
8. Pilz S, Tomaschitz A, Drechsler C et al. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res 2010; 54: 1103-1113
9. Pittas AG, Chung M, Trikalinos T et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307-314
10. Pilz S, Tomaschitz A, Drechsler C et al. Vitamin D supplementation: A promising approach for the prevention and treatment of strokes. Curr Drug Targets 2011; 12: 88-96
11. Pilz S, Tomaschitz A, Obermayer-Pietsch B et al. Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res 2009; 29: 3699-3704
12. Shoenfeld N, Amital H, Shoenfeld Y. The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 2009; 5: 99-105
13. Yamshchikov AV, Desai NS, Blumberg HM et al. Vitamin D for treatment and prevention of infectious diseases: A systematic review of randomized controlled trials. Endocr Pract 2009; 15: 438-449
14. Bouillon R, Carmeliet G, Verlinden L et al. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev 2008; 29: 726-776
15. Kidney-Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney diseasemineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009; 113: S1-S130
16. Kooienga L, Fried L, Scragg R et al. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD. Am J Kidney Dis 2009; 53: 408-416
17. Jean G, Souberbielle JC, Chazot C. Monthly cholecalciferol administration in haemodialysis patients: A simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant 2009; 24: 3799-3805
18. Stubbs JR, Idiculla A, Slusser J et al. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol 2010; 21: 353-361
19. Matias PJ, Jorge C, Ferreira C et al. Cholecalciferol supplementation in hemodialysis patients: Effects in mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 2010; 5: 905-911
20. Kandula P, Dobre M, Schold JD et al. Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2011; 6: 50-62
21. Ravani P, Malberti F, Tripepi G et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009; 75: 88-95
22. Mehrotra R, Kermah DA, Salusky IB et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 2009; 76: 977-983
23. Jassal SK, Chonchol M, von Mühlen D et al. Vitamin D, parathyroid hormone, and cardiovascular mortality in older adults: The Rancho Bernardo Study. Am J Med 2010; 123: 1114-20
24. Pilz S, März W, Wellnitz B et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008; 93: 3927-3935
25. Pilz S, Dobnig H, Fischer JE et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008; 39: 2611-2613
26. Pilz S, Dobnig H, Winklhofer-Roob B et al. Low serum levels of 25- hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol Biomarkers Prev 2008; 17: 1228-1233
27. Winkelmann BR, Marz W, Boehm BO et al. Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001; 2: S1-S73
28. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150: 604-612
29. The International Expert Committee. International expert committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334
30. Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007; 72: 1004-1013
31. Barreto DV, Barreto FC, Liabeuf S et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1128-1135
32. Wang AY, Lam CW, Sanderson JE et al. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: A 3-y prospective cohort study. Am J Clin Nutr 2008; 87: 1631-1638
33. Drechsler C, Pilz S, Obermayer-Pietsch B et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J 2010; 31: 2253-2261
34. Gracia-Iguacel C, Gallar P, Qureshi AR et al. Vitamin D deficiency in dialysis patients: Effect of dialysis modality and implications on outcome. J Ren Nutr 2010; 20: 359-367
35. Pecovnik-Balon B, Jakopin E, Bevc S et al. Vitamin D and mortality as a novel nontraditional risk factor for mortality in hemodialysis patients. Ther Apher Dial 2009; 13: 268-272
36. Drechsler C, Verduijn M, Pilz S et al. Vitamin D status and clinical outcomes in incident dialysis patients: Results from the NECOSAD study. Nephrol Dial Transplant. doi: 10.1093/ndt/gfq606
37. Pilz S, Tomaschitz A, Drechsler C et al. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 2010; 31: 1591-1598
38. De Zeeuw D, Agarwal R, Amdahl M et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): A randomized controlled trial. Lancet 2010; 376: 1543-1551
39. Tomaschitz A, Pilz S, Ritz E et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 2010; 411: 1354-1360
40. Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1730-1737
41. Kalantar-Zadeh K, Kovesdy CP. Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1529-1539
42. Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 2005; 35: 290-304
43. Hathcock JN, Shao A, Vieth R et al. Risk assessment for vitamin D. Am J Clin Nutr 2007; 85: 6-18
44. Souberbielle JC, Body JJ, Lappe JM et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010; 9: 709-715